Quantra, innovative bleeding management solution.
Stago is proud to offer an innovative bleeding management solution, the Quantra
T
his innovative vitro diagnostic platform is designed to assess a patient’s coagulation status by measuring changes in viscoelastic properties of a blood sample during clot formation in critical care settings where bleeding could be a concern.
A fully automated device, the Quantra analyser is designed for use by clinical staff with no specialised training, requires less than one-minute hands-on time, and provides easy-to-interpret actionable information to guide the management of critical bleeding in ≤ 15 minutes.
The Quantra is based on a patented technology, Sonic Estimation of Elasticity via Resonance (SEER) Sonorheometry which uses high frequency ultrasound to measure the shear modulus (clot strength) of whole blood during coagulation, and can offer faster time-to-results, and increased sensitivity to weak clots compared to traditional viscoelastic testing systems.
Two cartridges are available; QPlus (cardiovascular and major orthopaedic surgery) and QStat (trauma and critical care and liver transplant) and provide a comprehensive measurement of coagulopathic parameters
Explore publications and clinical studies on the Quantra
Your patient is bleeding
See the Quantra in action "Your Patient is Bleeding"
QLabs FIB Monitoring system
Introducing our New Fibrinogen POC System
Stago has launched qLabs FIB, a novel point-of-care fibrinogen monitoring system, for rapid measurement of functional fibrinogen levels from a single drop of citrated whole blood. With a hands-on time of <60 secs, it delivers results in ≤10 minutes. The lower the fibrinogen level, the faster the time to result. QLabs FIB enables rapid, goal directed therapy with early administration of fibrinogen supplementation in the management of critical bleeds such as post-partum haemorrhage.
Designed for ease and speed when it matters
Running a test – a simple guide
Features and Specifications
